89 related articles for article (PubMed ID: 10360855)
1. L-arginine infusion dilates coronary vasculature in patients undergoing coronary bypass surgery.
Wallace AW; Ratcliffe MB; Galindez D; Kong JS
Anesthesiology; 1999 Jun; 90(6):1577-86. PubMed ID: 10360855
[TBL] [Abstract][Full Text] [Related]
2. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology.
Drexler H; Fischell TA; Pinto FJ; Chenzbraun A; Botas J; Cooke JP; Alderman EL
Circulation; 1994 Apr; 89(4):1615-23. PubMed ID: 8149529
[TBL] [Abstract][Full Text] [Related]
3. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A
Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355
[TBL] [Abstract][Full Text] [Related]
4. Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries.
Dubois-Randé JL; Zelinsky R; Roudot F; Chabrier PE; Castaigne A; Geschwind H; Adnot S
Am J Cardiol; 1992 Nov; 70(15):1269-75. PubMed ID: 1442577
[TBL] [Abstract][Full Text] [Related]
5. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms.
Egashira K; Hirooka Y; Kuga T; Mohri M; Takeshita A
Circulation; 1996 Jul; 94(2):130-4. PubMed ID: 8674170
[TBL] [Abstract][Full Text] [Related]
6. Role of nitric oxide in vascular tone and in reactivity to isoproterenol and adenosine in the goat coronary circulation.
Fernández N; Sánchez MA; Martínez MA; García-Villalón AL; Monge L; Gómez B; Diéguez G
Eur J Pharmacol; 2000 Jan; 387(1):93-9. PubMed ID: 10633166
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs.
Canty JM; Schwartz JS
Circulation; 1994 Jan; 89(1):375-84. PubMed ID: 8281673
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide does not mediate coronary vasodilation by isoflurane.
Crystal GJ; Kim SJ; Salem MR; Khoury E; Gurevicius J
Anesthesiology; 1994 Jul; 81(1):209-20. PubMed ID: 8042788
[TBL] [Abstract][Full Text] [Related]
9. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis.
Gurevicius J; Salem MR; Metwally AA; Silver JM; Crystal GJ
Am J Physiol; 1995 Jan; 268(1 Pt 2):H39-47. PubMed ID: 7530920
[TBL] [Abstract][Full Text] [Related]
10. L-arginine improves post-ischemic vasodilation in coronary heart disease patients taking vasodilating drugs.
Iannuzzi A; Iannuzzo G; Sapio C; Pauciullo P; Iorio D; Spampinato N; Mancini M; Rubba P
J Cardiovasc Pharmacol Ther; 2001 Apr; 6(2):121-7. PubMed ID: 11509918
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-dependent relaxation competes with alpha 1- and alpha 2-adrenergic constriction in the canine epicardial coronary microcirculation.
Jones CJ; DeFily DV; Patterson JL; Chilian WM
Circulation; 1993 Apr; 87(4):1264-74. PubMed ID: 8384938
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of acetylcholine-induced vasoconstriction by L-arginine is related to the progression of atherosclerosis.
Otsuji S; Nakajima O; Waku S; Kojima S; Hosokawa H; Kinoshita I; Okubo T; Tamoto S; Takada K; Ishihara T
Am Heart J; 1995 Jun; 129(6):1094-100. PubMed ID: 7754938
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
Zhao L; Lu J; Wang C; Zhao W; Qing E; Ma J
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1208-11. PubMed ID: 24090805
[TBL] [Abstract][Full Text] [Related]
14. Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension.
Panza JA; Casino PR; Badar DM; Quyyumi AA
Circulation; 1993 May; 87(5):1475-81. PubMed ID: 8491002
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nitric oxide synthesis augments centrally induced sympathetic coronary vasoconstriction in cats.
Goodson AR; Leibold JM; Gutterman DD
Am J Physiol; 1994 Oct; 267(4 Pt 2):H1272-8. PubMed ID: 7943371
[TBL] [Abstract][Full Text] [Related]
16. Differential contribution of nitric oxide to regulation of vascular tone in coronary conductance and resistance arteries: intravascular ultrasound studies.
Sudhir K; MacGregor JS; Amidon TM; Gupta M; Yock PG; Chatterjee K
Am Heart J; 1994 Apr; 127(4 Pt 1):858-65. PubMed ID: 7512309
[TBL] [Abstract][Full Text] [Related]
17. Coronary vasoconstriction produced by vasopressin in anesthetized goats. Role of vasopressin V1 and V2 receptors and nitric oxide.
Fernández N; García JL; García-Villalón AL; Monge L; Gómez B; Diéguez G
Eur J Pharmacol; 1998 Jan; 342(2-3):225-33. PubMed ID: 9548390
[TBL] [Abstract][Full Text] [Related]
18. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic and biochemical responses to L-arginine and L-lysine infusions in normal subjects: L-arginine-induced vasodilatation cannot be explained by non-specific effects of cationic amino acids.
Smulders RA; Aarsen M; Teerlink T; De Vries PM; Van Kamp GJ; Donker AJ; Stehouwer CD
Clin Sci (Lond); 1997 Apr; 92(4):367-74. PubMed ID: 9176035
[TBL] [Abstract][Full Text] [Related]
20. The LargPAD Trial: Phase IIA evaluation of l-arginine infusion in patients with peripheral arterial disease.
Kashyap VS; Lakin RO; Campos P; Allemang M; Kim A; Sarac TP; Hausladen A; Stamler JS
J Vasc Surg; 2017 Jul; 66(1):187-194. PubMed ID: 28366306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
